220 related articles for article (PubMed ID: 16273897)
1. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis.
Innes JF; Little CB; Hughes CE; Caterson B
Am J Vet Res; 2005 Oct; 66(10):1679-85. PubMed ID: 16273897
[TBL] [Abstract][Full Text] [Related]
2. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
3. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
4. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Little CB; Hughes CE; Curtis CL; Janusz MJ; Bohne R; Wang-Weigand S; Taiwo YO; Mitchell PG; Otterness IG; Flannery CR; Caterson B
Matrix Biol; 2002 Apr; 21(3):271-88. PubMed ID: 12009333
[TBL] [Abstract][Full Text] [Related]
6. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
7. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
Sandy JD; Verscharen C
Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
[TBL] [Abstract][Full Text] [Related]
9. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis.
Sandy JD
Osteoarthritis Cartilage; 2006 Feb; 14(2):95-100. PubMed ID: 16257242
[TBL] [Abstract][Full Text] [Related]
10. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.
Lohmander LS; Neame PJ; Sandy JD
Arthritis Rheum; 1993 Sep; 36(9):1214-22. PubMed ID: 8216415
[TBL] [Abstract][Full Text] [Related]
11. Calpain is involved in C-terminal truncation of human aggrecan.
Struglics A; Hansson M
Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
[TBL] [Abstract][Full Text] [Related]
12. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
[TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
17. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.
Sandy JD; Flannery CR; Neame PJ; Lohmander LS
J Clin Invest; 1992 May; 89(5):1512-6. PubMed ID: 1569188
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
[TBL] [Abstract][Full Text] [Related]
19. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.
Larsson S; Lohmander LS; Struglics A
Arthritis Res Ther; 2009; 11(3):R92. PubMed ID: 19545413
[TBL] [Abstract][Full Text] [Related]
20. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
Tortorella MD; Pratta MA; Fox JW; Arner EC
J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
